LIFTT invests in Keyron’s anti-diabetes and obesity device Your browser does not seem to support iframes. Click here to read this PDF. Convert your PDF to digital flipbook ↗ LIFTT Venture Capital Italia2021-12-28T11:26:07+00:0022 December 2021| Share FacebookTwitterLinkedInWhatsAppEmail